Supplement Own-Labeler’s GMP Stumble Reveals AER Slip
This article was originally published in The Rose Sheet
FDA warns own-labelers ProSupps USA and Cape Fear Naturals about GMP violations, also pointing out ProSupps dropped the ball on submitting serious AERs to FDA and Cape Fear Naturals made drug claims including “improve blood pressure and cholesterol.”
You may also be interested in...
An FDA inspection found two serious adverse event reports Market America received were not forwarded to the agency as required. Its response didn't answer whether it would review its records "to determine if a serious adverse event report should be submitted to FDA.”
Serious adverse events accounted for less than 1% of 41,121 adverse events reported to two supplement firms over 2.5 years, with weight loss agents and products for glycemic management accounting for majority, says a study by regulatory compliance consultants and CRN executives.
Warnings from FDA's Office of Regulatory Affairs make clear that failing to document compliance with each GMP requirement renders those parts of the process noncompliant. Warning letters posted March 22 also include FDA's latest enforcement against firms marketing bulk caffeine.